Oruka Therapeutics (ORKA) Shares Slip After Mid-Stage Trial Results; Market Weighs Growth Prospects

As reported by gurufocus.com

On September 23, 2026, Oruka Therapeutics Inc (NASDAQ: ORKA) experienced a decline in its stock price following the release of 28-week data from its EVERLAST-A ...

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on gurufocus.com ↗

Market Samachar is a news aggregator. This article was originally published by gurufocus.com. Tap the button above to read the full story on their site.

INDIAN Top 3 IPOs Performance Report Card: Ahead of NSE, know how Hyundai, LIC, Paytm fared on exchange debut day; data details mint - markets
INDIAN Wall Street falls as oil prices, Treasury yields rise mint - markets
INDIAN Nifty outlook, guide tomorrow: Why 23,600 matters; bullish candle formed, check resistance, support levels | Thu 24 Sep mint - markets
INDIAN Top breakout stocks to buy today: Aptus, KRBL, Tata Steel, Radico, GNFC by Sumeet Bagadia | Targets mint - markets
INDIAN NSE IPO may see modest debut despite strong institutional demand mint - markets
INDIAN Top stocks in focus today: Investors must watch GHCL, Max Estates, Bharat Dynamics shares on Thu, 24 Sept | Triggers mint - markets
INDIAN Sedemac Mechatronics block deal: A91, Xponentia, HDFC Life likely to offload 10% stake: Report mint - markets
INDIAN Wall Street slips as oil and bond yields rise, Trump-Xi meet in focus mint - markets

Oruka Therapeutics (ORKA) Shares Slip After Mid-Stage Trial Results; Market Weighs Growth Prospects

More from Market Samachar